ghk cu keratosis pilaris What is Pilaris? | What Causes Keratosis Pilaris? | Soft Services Treatment of Keratosis Pilaris –
Description
In activated macrophage cultures, GHK-Cu administration reduces the production of pro-inflammatory cytokines including interleukin-1, tumor necrosis factor-, and interleukin-6 by 40-65% while simultaneously increasing the production of anti-inflammatory mediators such as interleukin-10 and transforming growth factor-
Thymosin Alpha-1 from True Form Peptides offers 99% purity for precise research
Sodium chloride
Dermatologists explain how to find relief and when to seek help.
Content: 10mg per vial
BPC-157, TB-500, and GHK-Cu are commonly discussed within peptide research and stacking strategies
